Related Experiment Video
Updated: Dec 3, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Vaccinations in the newborn
1Australian National University Medical School, Canberra, Australia.
Insights
Neonatal immunization protects vulnerable infants from serious infections. Despite challenges like immature immune systems, vaccines like Hepatitis B, BCG, and OPV are safe and effective at birth.
Area of Science:
- Immunology
- Pediatrics
- Vaccinology
Background:
- Neonates possess immature immune systems, increasing susceptibility to severe infections.
- Challenges in neonatal vaccination include maternal antibody interference and a Th2-skewed immune response.
- Despite these hurdles, some vaccines demonstrate efficacy in newborns.
Purpose of the Study:
- To review current neonatal vaccination practices, including those for high-risk preterm infants.
- To explore novel strategies for improving vaccine responses in neonates.
- To highlight the importance of early immunization in this vulnerable population.
Main Methods:
- Literature review of current neonatal vaccines and their efficacy.
- Analysis of immunological challenges in the neonatal period.
- Exploration of emerging vaccine technologies and approaches.
Main Results:
- Hepatitis B, BCG, and OPV are currently administered to neonates, proving safe and effective.
- Certain antigen-adjuvant combinations can induce protective immune responses in newborns.
- Ongoing research aims to overcome immunological barriers to enhance neonatal vaccine efficacy.
Conclusions:
- Neonatal vaccination is crucial for preventing life-threatening infections in infants.
- Existing vaccines show promise, but further advancements are needed for optimal protection.
- Novel approaches are being investigated to improve the immunogenicity and effectiveness of vaccines in neonates.
Abstract:
Neonatal immunisation includes vaccination in the first 4 weeks of life (Neonatal period) as well as in high-risk preterm infants in the first few months (until 44 weeks corrected gestational age). Neonates have an immature immune system, which renders them highly susceptible to life-threatening infections. This highlights the importance of vaccination in this vulnerable population; however, at the same time also making it challenging because of their inability to generate a protective immune response. Other challenges include interference from maternal antibodies and excessive skewing towards T Helper Cell Type 2 (Th2) immunity. Despite these challenges, several vaccines have been developed and proven safe and effective at birth. Presently, there are 3 vaccines - Hepatitis B vaccine, Bacillus Calmette-Guerine (BCG) and Oral Polio vaccine (OPV) widely used in neonates, which provides evidence that certain antigen-adjuvant combinations can elicit protective neonatal responses. This review focusses on current vaccinations in neonates, including preterm infants and highlights some novel approaches to enhance neonatal vaccination.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Rh Blood Group
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

